Abstract

BackgroundThis study compared the combination of estimated glomerular filtration rate (eGFR) and urine albumin-to-creatinine ratio (UACR) vs. eGFR and urine protein reagent strip testing to determine chronic kidney disease (CKD) prevalence, and each method’s ability to predict the risk for cardiovascular events in the general Japanese population.MethodsBaseline data including eGFR, UACR, and urine dipstick tests were obtained from the general population (n = 22 975). Dipstick test results (negative, trace, positive) were allocated to three levels of UACR (<30, 30–300, >300), respectively. In accordance with Kidney Disease Improving Global Outcomes CKD prognosis heat mapping, the cohort was classified into four risk grades (green: grade 1; yellow: grade 2; orange: grade 3, red: grade 4) based on baseline eGFR and UACR levels or dipstick tests.ResultsDuring the mean follow-up period of 5.6 years, 708 new onset cardiovascular events were recorded. For CKD identified by eGFR and dipstick testing (dipstick test ≥ trace and eGFR <60 mL/min/1.73 m2), the incidence of CKD was found to be 9 % in the general population. In comparison to non-CKD (grade 1), although cardiovascular risk was significantly higher in risk grades ≥3 (relative risk (RR) = 1.70; 95 % CI: 1.28–2.26), risk predictive ability was not significant in risk grade 2 (RR = 1.20; 95 % CI: 0.95–1.52). When CKD was defined by eGFR and UACR (UACR ≥30 mg/g Cr and eGFR <60 mL/min/1.73 m2), prevalence was found to be 29 %. Predictive ability in risk grade 2 (RR = 1.41; 95 % CI: 1.19–1.66) and risk grade ≥3 (RR = 1.76; 95 % CI: 1.37–2.28) were both significantly greater than for non-CKD. Reclassification analysis showed a significant improvement in risk predictive abilities when CKD risk grading was based on UACR rather than on dipstick testing in this population (p < 0.001).ConclusionsAlthough prevalence of CKD was higher when detected by UACR rather than urine dipstick testing, the predictive ability for cardiovascular events from UACR-based risk grading was superior to that of dipstick-based risk grading in the general population.

Highlights

  • This study compared the combination of estimated glomerular filtration rate and urine albumin-to-creatinine ratio (UACR) vs. eGFR and urine protein reagent strip testing to determine chronic kidney disease (CKD) prevalence, and each method’s ability to predict the risk for cardiovascular events in the general Japanese population

  • A recent metaanalysis obtained from 1.5 million inhabitants in mainly Western populations reported that albuminuria levels are important for evaluating overall risk for CKD independent of estimated glomerular filtration rate [4]

  • In accordance with Kidney Disease Improving Global Outcomes (KDIGO) recommendations, several clinical practice guidelines in Europe, Australia, and Japan have recommended that prognostic grading for CKD should be based on a combination of urine albumin levels and eGFR [5,6,7]

Read more

Summary

Methods

Study participants This study was a prospective community-based cohort study examining cardiovascular events in Iwate Prefecture in northern Honshu, Japan. A total of 22 975 participants were enrolled who had complete data for eGFR, UACR, and dipstick urinalysis for proteinuria with no past history of stroke or myocardial infarction (7 841 men and 15 134 women, aged 40–89 years, mean age of 62.9 years). To determine concordance between two types of urine protein levels on a dichotomous outcome of UACR (300) and the urine dipstick test (negative, trace, positive), the kappa statistic was calculated. Testing the utility of CKD risk grading employing UACR rather than dipstick testing was performed by reclassification tables and tested by Net Reclassification Improvement (NRI) and Integrated Discrimination Improvement (IDI) using the R 3.0.2 software package (www.r-project.org)

Results
Conclusions
Background
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call